Same-day Topamax appointment

If you’re struggling with binge eating disorder (BED) and wondering whether you can access treatment through telehealth, the short answer is yes—and it’s easier than you might think. As of 2026, telehealth has become a legitimate, legally sound, and increasingly accessible way to receive evaluation and medication for BED across the United States.

This guide will walk you through everything you need to know about getting BED treatment online, including which medications you can receive, what the legal landscape looks like, and how to navigate the process safely.

Understanding Binge Eating Disorder and Telehealth Treatment

Binge eating disorder is the most common eating disorder in the United States, affecting millions of people who experience recurring episodes of eating large amounts of food while feeling a loss of control. Unlike other eating disorders, BED doesn’t involve purging behaviors, but it carries serious physical and emotional consequences.

The good news? Treatment is available, and telehealth has opened new doors for people who might have struggled to access care due to location, time constraints, or the stigma sometimes associated with seeking help for eating disorders.

What Makes Telehealth Legal for BED Medications?

The medications most commonly prescribed for BED through telehealth platforms—topiramate (Topamax) and bupropion (Wellbutrin)—are non-controlled substances. This is crucial because it means they fall outside the strict federal regulations (the Ryan Haight Act) that govern controlled substance prescribing via telehealth.

Since these medications aren’t classified as controlled substances by the DEA, healthcare providers can legally prescribe them through telehealth in every state without the in-person visit requirements that apply to medications like stimulants or opioids. The pandemic-era telehealth flexibilities that made headlines primarily affected controlled substances—medications like Topamax and Wellbutrin were always permissible via telehealth and remain so today.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Two Main Medications for BED: What You Need to Know

Topiramate (Topamax)

What it is: Originally FDA-approved for seizures and migraine prevention, topiramate is frequently prescribed off-label for binge eating disorder.

How it works for BED: Research suggests topiramate can help reduce binge eating episodes by affecting neurotransmitters that regulate appetite and impulse control. Many patients also experience modest weight loss, though this isn’t the primary goal of treatment.

What to expect:

• Your provider will typically start you on a low dose and gradually increase it
• Common side effects include tingling in hands/feet, changes in taste (especially with carbonated beverages), and cognitive effects like word-finding difficulty
• Treatment requires patience—it may take several weeks to see the full benefit
• Regular follow-ups are essential to monitor effectiveness and side effects

Important safety considerations:

• Not recommended during pregnancy—topiramate has been linked to birth defects, particularly cleft palate, when taken during the first trimester
• Women of childbearing age should use effective contraception
• Requires gradual tapering when discontinuing to avoid seizure risk
• Your provider will monitor for metabolic and cognitive side effects

Bupropion (Wellbutrin)

What it is: An antidepressant FDA-approved for depression and smoking cessation, also prescribed off-label for BED.

How it works for BED: Bupropion affects dopamine and norepinephrine, which can help regulate mood and reduce the frequency of binge eating episodes. It may be particularly helpful if you also experience depression or low energy.

What to expect:

• Effects may become noticeable within 1-2 weeks, though full benefits can take longer
• Generally well-tolerated with fewer sexual side effects than other antidepressants
• Can provide an energy boost, which some people find helpful
• Available in extended-release formulations for once-daily dosing

Critical contraindications:

• Do not use if you have a history of bulimia or anorexia nervosa—this significantly increases seizure risk
• Contraindicated in people with seizure disorders
• Avoid alcohol while taking bupropion due to increased seizure risk
• Not recommended with certain medications (MAOIs, other bupropion products)

Black Box Warning: Like all antidepressants, bupropion carries a warning about increased risk of suicidal thoughts in people under 25. Your provider should monitor you closely, especially when starting treatment or adjusting doses.

State-by-State Telehealth Access: What the Laws Say

While federal law allows telehealth prescribing of non-controlled medications nationwide, individual states have their own additional requirements. Here’s what you need to know about the most common scenarios:

States with No In-Person Requirements

The majority of states—including California, New York, Texas, Florida, Michigan, and Wisconsin—have no mandatory in-person visit requirement for non-controlled medications prescribed via telehealth. In these states, a comprehensive telehealth evaluation meets the legal standard for establishing a patient-provider relationship.

California has been particularly progressive, with 2025 legislation (AB 1503) explicitly recognizing that even asynchronous telehealth (like detailed online questionnaires combined with provider review) can constitute an appropriate examination for prescribing non-controlled medications, as long as it meets the standard of care.

States Requiring Periodic In-Person Follow-Ups

A handful of states—including Alabama, Georgia, and New Hampshire—have laws requiring periodic in-person examinations for ongoing telehealth treatment:

Alabama: If you receive more than four telehealth visits in 12 months for the same condition, state law requires an in-person visit within that year. However, this can be satisfied by seeing any qualified provider (not necessarily your telehealth prescriber), including a collaborating physician or local practitioner.

Georgia: Requires an attempt at an in-person examination at least annually for ongoing telemedicine care. Initial evaluation can be done via telehealth as long as it’s equivalent to an in-person exam.

New Hampshire: Allows telehealth prescribing (even for some controlled substances as of 2025), but requires a subsequent in-person exam by a prescriber at least every 12 months for continued treatment.

What This Means for You

Even in states with periodic in-person requirements, you can start treatment entirely online. The in-person visit requirements are for ongoing care, typically after several months of treatment. Additionally, these requirements often can be met by seeing a local provider for a general check-up, not necessarily by traveling to see your telehealth prescriber in person.

Who Can Prescribe BED Medications via Telehealth?

Understanding who can prescribe your medications is important, especially since regulations vary by provider type and state.

Medical Doctors (MDs) and Doctors of Osteopathy (DOs)

Physicians can prescribe both topiramate and bupropion via telehealth in all 50 states, provided they’re licensed in your state. This is the most straightforward scenario with the fewest regulatory complications.

Nurse Practitioners (NPs)

The landscape for NP prescribing has evolved significantly, with 34 states plus DC now granting NPs full practice authority—meaning they can evaluate, diagnose, and prescribe independently without physician oversight.

States with NP full practice authority include:

• California (after 3 years of supervised practice under AB 890)
• New York (after 3,600 hours of supervised practice)
• New Hampshire, Michigan, and Wisconsin (all granted full authority in recent years)
• Delaware (after 2-year collaboration period)

In states without full practice authority—like Texas, Florida, Georgia, and Alabama—NPs must work under a collaborative or supervisory agreement with a physician. This doesn’t usually affect your care experience; it’s a behind-the-scenes regulatory requirement. Your prescription may show both the NP’s and supervising physician’s names, but the NP is typically your primary provider.

Physician Assistants (PAs)

PAs can prescribe non-controlled medications in all states, but they always work under physician supervision (unlike NPs in full-practice-authority states). This supervision is usually formalized through a practice agreement, but like with NPs in collaborative states, it shouldn’t significantly impact your access to care.

The Telehealth Evaluation Process: What to Expect

Initial Consultation

A legitimate telehealth evaluation for BED should be comprehensive and thorough—typically 30 minutes or longer for your first appointment. If you encounter a service that promises prescriptions after a 5-minute questionnaire, that’s a red flag.

Your provider will ask detailed questions about:

Your eating patterns:

• Frequency and characteristics of binge eating episodes
• What triggers binges
• How you feel during and after binge episodes
• Whether you’ve tried to control the behavior
• Impact on your daily life and relationships

Diagnostic criteria:To receive a BED diagnosis and treatment, you’ll need to meet DSM-5 criteria, which include:

• Recurrent episodes of binge eating (eating an excessive amount within a discrete period)
• Feeling a lack of control during these episodes
• Experiencing distress about binge eating
• Binge eating occurring at least once weekly for three months
• Absence of compensatory behaviors like purging (which would suggest a different eating disorder)

Medical and psychiatric history:

• Current and past medical conditions
• Current medications and supplements
• History of seizures or eating disorders (critical for medication safety)
• Mental health history, including depression, anxiety, or suicidal thoughts
• Substance use history
• Pregnancy status or plans

Safety screening:Your provider must screen for contraindications to the medications being considered. For example, they’ll specifically ask about history of bulimia or anorexia before considering bupropion, and about pregnancy and contraception use before prescribing topiramate.

Identity Verification and Documentation

Don’t be surprised when your telehealth provider asks you to verify your identity and location at the start of your visit. Many states require this to ensure:

• The provider is licensed in your state
• You’re physically located in a state where they can legally treat you
• Accurate medical records are maintained

This is standard practice and protects both you and the provider.

Treatment Planning

A quality telehealth provider won’t just prescribe medication and send you on your way. They should discuss:

Comprehensive treatment options:

• Medication options with pros and cons of each
• Psychotherapy, particularly cognitive-behavioral therapy (CBT) or dialectical behavior therapy (DBT), which are evidence-based for BED
• Nutritional counseling
• Support groups and additional resources

While medication can be helpful, the gold-standard treatment for BED typically includes therapy. Reputable providers will at least mention this, even if your immediate focus is medication.

Informed consent:Because topiramate and bupropion are prescribed ‘off-label’ for BED (they’re FDA-approved for other conditions), your provider should explain:

• What off-label prescribing means
• The evidence supporting use for BED
• Potential risks and benefits
• Alternative treatment options
• Why they’re recommending this particular medication for you

Off-label prescribing is completely legal and extremely common—about 20% of all prescriptions in the U.S. are off-label. For BED specifically, research supports the use of both topiramate and bupropion, even though neither has formal FDA approval for this indication.

Safety Considerations and Red Flags

The telehealth industry has matured significantly since the pandemic, but it’s important to recognize quality care versus problematic practices.

Signs of Quality Telehealth Care

Thorough evaluation process:

• Comprehensive intake questionnaire
• Live video consultation (not just text-based)
• Provider asks follow-up questions and seeks clarification
• Detailed discussion of treatment options
• Clear explanation of medication risks and benefits

Appropriate clinical boundaries:

• Provider sets realistic expectations about treatment timeline and outcomes
• Discusses when in-person care might be necessary
• Won’t prescribe medications you’re not appropriate for, even if you request them
• Requires follow-up appointments to monitor progress

Professional infrastructure:

• Licensed providers clearly identified with credentials listed
• Secure, HIPAA-compliant platform
• Proper documentation and medical records
• Prescriptions sent electronically to licensed pharmacies
• Clear policies about emergencies and after-hours care

Red Flags to Watch For

Promises before evaluation:Any service that guarantees you’ll receive a prescription before completing a proper evaluation is practicing questionable medicine. Legitimate providers evaluate first, then determine appropriate treatment.

Minimal screening:If a provider doesn’t ask detailed questions about your medical history, particularly contraindications to the medications they’re prescribing, this suggests inadequate care.

Selling medications directly:Legitimate telehealth services send prescriptions to regular pharmacies—they don’t sell you medications directly from their own inventory (except for specific FDA-approved telemedicine pharmacy models). If a service wants to ship you pills from their own warehouse, be cautious.

Pressure tactics:Quality healthcare providers don’t use high-pressure sales tactics or create artificial urgency (‘Sign up now or lose this price!’). They provide information and let you make informed decisions.

One-size-fits-all approach:If every patient seems to get the same medication regardless of individual circumstances, or if there’s no consideration of therapy or other non-medication approaches, this suggests inadequate personalized care.

Who Should NOT Use Telehealth for BED Medication

While telehealth expands access to BED treatment, it’s not appropriate for everyone. You may need in-person care if you have:

Medical Contraindications

Active or recent bulimia/anorexia:If you have a current or recent history of purging behaviors, bupropion is contraindicated due to significantly increased seizure risk. Your telehealth provider should not prescribe it and should recommend alternative treatments.

Seizure disorders:Both bupropion and topiramate require careful consideration in people with seizure disorders. While topiramate is actually an anti-seizure medication, it needs specialist oversight. Bupropion lowers seizure threshold and may not be safe depending on your specific situation.

Pregnancy or planning pregnancy:Topiramate poses significant fetal risks, particularly in the first trimester. Most telehealth providers won’t initiate topiramate if you’re pregnant, planning pregnancy, or not using reliable contraception. If you’re already on topiramate and become pregnant, don’t stop abruptly—contact your provider immediately.

Severe medical instability:If your binge eating has resulted in severe obesity with acute health complications, uncontrolled diabetes, severe hypertension, or other urgent medical issues, you may need comprehensive in-person evaluation first.

Need for Controlled Medications

The only FDA-approved medication for BED is actually lisdexamfetamine (Vyvanse), a controlled stimulant. Telehealth prescribing of controlled substances is much more restricted, and many legitimate telehealth platforms don’t prescribe stimulants due to regulatory concerns and abuse potential.

If evaluation suggests you might benefit from Vyvanse or another controlled medication, your telehealth provider should refer you to an in-person specialist who can provide this level of care.

Complex Presentations

Telehealth works best for straightforward cases. You may need in-person care if you have:

• Multiple psychiatric comorbidities requiring complex medication management
• Active suicidal ideation requiring intensive monitoring
• Need for frequent physical examinations or lab monitoring
• Cognitive impairment affecting your ability to engage in telehealth
• Lack of privacy or safety in your home environment for video consultations

Prescription Logistics and Follow-Up Care

How You’ll Receive Your Medication

After your evaluation, if medication is appropriate, your provider will send an electronic prescription to a pharmacy of your choice. This is how nearly all prescriptions work now, whether from telehealth or in-person providers.

Prescription details:

• For non-controlled medications like topiramate and bupropion, providers can typically authorize multiple refills (commonly up to 6-11 months depending on state regulations)
• You can use your insurance if your plan covers telehealth visits and prescriptions
• You can also pay cash at the pharmacy—both medications are available as generics and relatively affordable

Using insurance:Many insurance plans now cover telehealth visits, though coverage specifics vary. At Klarity Health, we work with both insurance and cash-pay patients, providing transparent pricing upfront so you know what to expect. If you’re paying out-of-pocket for the visit, generic topiramate and bupropion at the pharmacy typically cost $10-$50 per month without insurance.

Follow-Up Schedule

Quality telehealth care includes regular follow-up, not just an initial prescription and then radio silence.

Typical follow-up schedule:

• 2-4 weeks: First follow-up to assess initial response, side effects, and tolerability. Dose adjustments often happen at this appointment.
• Monthly visits: For the first few months as your provider monitors your progress and optimizes dosing
• Every 2-3 months: Once stable on medication, with more frequent visits if needed

What happens during follow-ups:

• Assessment of binge eating frequency and severity
• Side effect monitoring
• Review of any other medications or health changes
• Weight and vital signs (you may be asked to check these at home)
• Adjustment of medication dose if needed
• Discussion of therapy and other supportive treatments
• Renewal of prescriptions

Even in states requiring periodic in-person visits, most of your care can happen via telehealth, with perhaps an annual check-up with a local provider to satisfy state requirements.

Recent Regulatory Changes and What They Mean for You

The regulatory landscape for telehealth continues to evolve, primarily around controlled substances, but it’s helpful to understand the broader context.

Federal Developments

DEA telehealth flexibilities:The emergency rules allowing telehealth prescribing of controlled substances (which began during the COVID-19 pandemic) have been extended through December 31, 2026. This extension doesn’t directly affect non-controlled BED medications, but it signals continued federal support for telehealth access.

Non-controlled medications:There has never been a federal restriction on telehealth prescribing of non-controlled medications like topiramate and bupropion. The Ryan Haight Act, which requires an in-person visit before prescribing controlled substances via telemedicine, explicitly doesn’t apply to non-controlled drugs.

State-Level Changes

Several states updated their telehealth laws in 2024-2025:

New Hampshire (SB 252, effective August 2025):Explicitly allowed telehealth prescribing of even Schedule II-IV controlled substances (with an annual in-person follow-up), modernizing the state’s approach to telemedicine.

New York (Final Rule, May 2025):Adopted an in-person exam requirement before prescribing controlled medications via telehealth once federal waivers end, but this does not affect non-controlled medications like those used for BED.

Michigan and Wisconsin:Both states passed legislation granting nurse practitioners full practice authority in 2025, expanding the pool of providers who can independently prescribe BED medications via telehealth.

California (AB 1503, 2025):Clarified that asynchronous telehealth and online evaluations can meet the ‘good faith examination’ standard for prescribing, further expanding telehealth flexibility.

What This Means for BED Treatment

The regulatory trajectory continues to favor telehealth access for conditions like BED. While there’s increased scrutiny on controlled substance prescribing (appropriately, to prevent abuse), this hasn’t negatively impacted access to non-controlled treatments. If anything, states are becoming more comfortable with telehealth and codifying it as a permanent fixture of healthcare delivery.

Klarity Health’s Approach to BED Treatment

At Klarity Health, we’ve built our telehealth platform specifically to make mental health and eating disorder treatment accessible, affordable, and clinically sound. Our approach to BED treatment reflects both regulatory requirements and clinical best practices:

Provider availability:We connect you with licensed psychiatric providers in your state—psychiatrists, psychiatric nurse practitioners, and physician assistants who specialize in eating disorders and mental health conditions. Our providers maintain active licenses in multiple states, helping us ensure you can get care wherever you are.

Transparent pricing:We believe you should know what healthcare costs before you commit. Whether you’re using insurance or paying out-of-pocket, we provide clear pricing information upfront. Initial evaluations and follow-up visits are priced transparently, with no surprise bills or hidden fees.

Insurance and cash pay options:We accept insurance from many major carriers and also offer competitive cash-pay rates for those without coverage or who prefer not to use insurance. This flexibility ensures cost doesn’t become a barrier to getting help.

Comprehensive care:While medication can be an important tool for BED, we view it as part of a comprehensive treatment approach. Our providers will discuss therapy options, nutritional counseling, and other supportive resources. We can coordinate with your existing therapist or help you find one if you’re not currently in therapy.

Safety first:Our providers follow strict protocols for evaluation and prescribing. We won’t prescribe medications you’re not appropriate for, even if you request them. We carefully screen for contraindications, maintain thorough documentation, and schedule appropriate follow-ups to monitor your progress.

Frequently Asked Questions

Do I need to have an in-person visit before getting BED medication online?

In most states, no. For non-controlled medications like topiramate and bupropion, a comprehensive telehealth evaluation meets the legal and clinical standard for initiating treatment. A few states (Alabama, Georgia, New Hampshire) require periodic in-person follow-ups for ongoing care, but even in these states, you can start treatment entirely online.

Will my insurance cover telehealth treatment for BED?

Many insurance plans now cover telehealth visits at the same rate as in-person visits, though policies vary. Check with your insurance provider about telehealth coverage for mental health services. At Klarity Health, we’ll verify your coverage before your appointment so you know what to expect.

How quickly can I get started with treatment?

At many telehealth platforms, including Klarity Health, you can often schedule an initial evaluation within days, sometimes even the same day. After your evaluation, if medication is appropriate, your prescription can be sent to a pharmacy within hours, allowing you to start treatment quickly.

Are there any medications that telehealth providers can’t prescribe for BED?

The main limitation is lisdexamfetamine (Vyvanse), the only FDA-approved medication for BED, which is a controlled stimulant. Due to stricter regulations around controlled substances, many telehealth platforms don’t prescribe stimulants. However, topiramate and bupropion (both non-controlled) have good research support for BED and are fully accessible via telehealth.

What if the medication doesn’t work or causes side effects?

This is exactly why regular follow-ups are important. If you experience side effects or aren’t seeing improvement, your provider can adjust the dose, switch medications, or discuss other treatment approaches. Never discontinue these medications abruptly without consulting your provider, especially topiramate, which requires gradual tapering.

Can I use telehealth if I live in a rural area?

Absolutely—this is one of the major advantages of telehealth. If you live in an area with limited access to eating disorder specialists, telehealth connects you with providers who might be hundreds of miles away but can still legally treat you as long as they’re licensed in your state.

Is telehealth as effective as in-person treatment?

Research increasingly shows that telehealth delivers comparable outcomes to in-person care for many mental health conditions, including eating disorders. The key is working with a qualified provider, maintaining regular follow-ups, and being honest and thorough in your communication during video visits.

Taking the First Step

If you’re struggling with binge eating disorder, telehealth offers a legitimate, accessible pathway to treatment. The medications discussed here—topiramate and bupropion—are legally and safely prescribable via telehealth across the United States, with well-established clinical evidence supporting their use.

The process is straightforward:

1. Schedule an evaluation with a licensed telehealth provider in your state
2. Complete a comprehensive assessment via video visit
3. Discuss treatment options including medication, therapy, and other supports
4. Receive your prescription electronically at your chosen pharmacy
5. Maintain regular follow-ups to monitor progress and adjust treatment

Getting Started with Klarity Health

At Klarity Health, we’ve made getting help for BED simple and accessible. Our providers are experienced in eating disorder treatment, our pricing is transparent, and we work with both insurance and cash-pay patients to ensure cost doesn’t stand between you and recovery.

Ready to take the first step? Visit Klarity Health to schedule your confidential evaluation with a licensed psychiatric provider who specializes in eating disorders. You can get started today—because you deserve support, and recovery is possible.

Research Currency Statement

Verified as of: January 4, 2026

DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Key Sources

1. U.S. Department of Health and Human Services. ‘DEA and HHS Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications.’ HHS Press Room, January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Health Law Blog, August 2025. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ CCHP Telehealth Policy Database, November-December 2025. https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ January 2025. https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. U.S. Food and Drug Administration. ‘Bupropion Hydrochloride Extended-Release Tablets Label.’ DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12